Keith Leonard, the chief executive of Kythera Biopharmaceuticals Inc., rang the Nasdaq opening bell Wednesday in New York, as the company announced positive results from clinical trials of its leading drug candidate....

Join our Membership to get the full story.


Are you a current Member? Sign In